Literature DB >> 666605

Internuclear ophthalmoplegia. II. Pursuit, optokinetic nystagmus, and vestibulo-ocular reflex.

R W Baloh, R D Yee, V Honrubia.   

Abstract

Smooth pursuit, optokinetic nystagmus (OKN) and the vestibulo-ocular reflex (VOR) were studied in four patients with internuclear ophthalmoplegia (two with bilateral and two with unilateral lesions). Horizontal smooth pursuit by an adducting eye on the side of a medial longitudinal fasciculus (MLF) lesion was normal in three of four patients; vertical pursuit was abnormal in all four. The horizontal VOR gain of slow components made by an adducting eye on the side of an MLF lesion was normal in all four patients. The vertical VOR gain was decreased in the two patients tested. It is concluded that either there are pathways independent of the MLF for horizontal pursuit and vestibular signals that are not available to vertical signals, or vertical pursuit and vestibular eye movements require a higher rate of oculomotor neuron firing than equal-velocity horizontal eye movements.

Entities:  

Mesh:

Year:  1978        PMID: 666605     DOI: 10.1001/archneur.1978.00500320010003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Characterization of ocular motor deficits in congenital facial weakness: Moebius and related syndromes.

Authors:  Janet C Rucker; Bryn D Webb; Tamiesha Frempong; Harald Gaspar; Thomas P Naidich; Ethylin Wang Jabs
Journal:  Brain       Date:  2014-02-21       Impact factor: 13.501

2.  Vestibulo-ocular reflex deficits with medial longitudinal fasciculus lesions.

Authors:  Swee T Aw; Luke Chen; Michael J Todd; Michael H Barnett; G Michael Halmagyi
Journal:  J Neurol       Date:  2017-09-06       Impact factor: 4.849

3.  Oblique saccades in internuclear ophthalmoplegia.

Authors:  Oded Rock; Andrea Albonico; Farnaz Javadian; Mohammad Ashkanani; Alisdair J G Taylor; Michael Dreyer; Jason J S Barton
Journal:  Exp Brain Res       Date:  2022-01-24       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.